For the latest COVID-19 campus news and resources, visit umassmed.edu/coronavirus.

Search Close Search
Search Close Search
Page Menu

Latest in Research

Getting Results…
  • Prestigious NIH Kirschstein Award to fund MD/PhD student’s research into impact of structural racism on health
     

    Prestigious NIH Kirschstein Award to fund MD/PhD student’s research into impact of structural racism on health

    MD/PhD student Zach Dyer, MPH, will use a three-year NIH grant to fine-tune the structural racism effect index he built for his thesis research and get it in front of policy makers.

    Read more
  • UMass Chan working with Evaxion to evaluate vaccine candidates for gonorrhea
    Research News

    UMass Chan working with Evaxion to evaluate vaccine candidates for gonorrhea

    UMass Chan Medical School has received a National Institutes of Health grant for preclinical development of gonorrhea vaccine candidates identified by Denmark biotech company Evaxion.

    Read more
  • Interest in point-of-care technologies increases among health care professionals during pandemic
    Research News

    Interest in point-of-care technologies increases among health care professionals during pandemic

    UMass Chan Medical School and UMass Lowell researchers report that interest among health care professionals in point-of-care technologies increased during the pandemic, based on results of identical surveys administered in late 2019 and late 2020.

    Read more
  • Gang Han and colleagues develop superfluorescence, light-emitting, nanocrystal alternative to lasers
    Research News

    Gang Han and colleagues develop superfluorescence, light-emitting, nanocrystal alternative to lasers

    Researchers at UMass Chan Medical School and North Carolina State University have developed a superfluorescence crystal nanoparticle that uses near-infrared light to safely produce laser-quality light at room temperature.

    Read more
  • Eviatar Yemini honored with 2022 Klingenstein-Simons Fellowship Award in Neuroscience
    Research News

    Eviatar Yemini honored with 2022 Klingenstein-Simons Fellowship Award in Neuroscience

    In his lab at UMass Chan Medical School, Eviatar Yemini, PhD, is working to develop a systems-biology model of a whole nervous system. Klingenstein-Simons Fellowship Awards support highly promising, early career scientists.

    Read more
  • UMass Chan BRIDGE Fund supports seven faculty projects with commercialization potential
    Research News

    UMass Chan BRIDGE Fund supports seven faculty projects with commercialization potential

    BRIDGE Innovation and Business Development at UMass Chan Medical School has awarded $2.2 million to seven faculty-led biomedical research projects.

    Read more
  • Partnerships key to Medical School’s success, Chancellor tells Worcester Homecoming audience
    Community News

    Partnerships key to Medical School’s success, Chancellor tells Worcester Homecoming audience

    Chancellor Michael F. Collins heralded the emergence of UMass Chan Medical School as both the state’s leading educator of primary care physicians and a research powerhouse in his June 9 keynote luncheon address for the inaugural Worcester Homecoming.

    Read more
  • Beyond COVID fatigue
    Community News

    Beyond COVID fatigue

    Valerie Wedge, LICSW, CEAP, and director of the Office of Well-Being at UMass Chan Medical School, said her office is seeing more confusion, depression and anger than a year ago, when COVID fatigue made its way into conversation.

    Read more
  • New studies to test performance of home COVID-19 tests for omicron
    Media, Research News

    New studies to test performance of home COVID-19 tests for omicron

    UMass Chan Medical School researchers and their partners in the National Institutes of Health Rapid Acceleration of Diagnostics initiative are starting new studies to determine if the performance of at-home COVID-19 antigen tests currently on the market in the U.S. is affected by the omicron variant.

    Read more
  • UMass Chan develops model to help clinicians discuss COVID-19 vaccines with pregnant women
    Research News

    UMass Chan develops model to help clinicians discuss COVID-19 vaccines with pregnant women

    A new training initiative funded by the CDC and developed at UMass Chan Medical School aims to help health care providers counsel patients who are hesitant about taking the COVID-19 vaccine while pregnant.

    Read more
  • Top story: UMass Medical School researchers to start trial of Moderna COVID-19 vaccine in teens
    Research News

    Top story: UMass Medical School researchers to start trial of Moderna COVID-19 vaccine in teens

    UMass Medical School researchers are about to start enrolling adolescents ages 12 through 17 in a clinical trial to test the COVID-19 mRNA vaccine made by Moderna. (Originally published on Jan. 26, 2021)

    Read more
  • UMass Chan clinical trial shows antisense oligonucleotide safely suppresses mutant ALS gene in pilot human study
    Research News

    UMass Chan clinical trial shows antisense oligonucleotide safely suppresses mutant ALS gene in pilot human study

    Robert H. Brown Jr., DPhil, MD, Jonathan Watts, PhD, and colleagues have shown the ability to suppress mutant forms of an ALS gene in a single-patient pilot study.

    Read more
  • UMass Medical School researchers to evaluate treatment options for early COVID-19 infection
    Research News

    UMass Medical School researchers to evaluate treatment options for early COVID-19 infection

    UMass Medical School is participating in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, which is evaluating investigational agents for treating early COVID-19.

    Read more
  • Roger Davis elected to American Academy of Arts & Sciences
    Research News

    Roger Davis elected to American Academy of Arts & Sciences

    Roger J. Davis, PhD, FRS, has been elected a member of the American Academy of Arts & Sciences in recognition of his research on stress signaling pathways that are connected to a range of diseases, such as arthritis, cancer, stroke, heart disease and diabetes.

    Read more
  • UMass Medical School helps lead NIH RADx to accelerate new COVID test technologies
    Research News

    UMass Medical School helps lead NIH RADx to accelerate new COVID test technologies

    The national effort to bring convenient, affordable and rapid testing technology for SARS-CoV-2 infection to market is moving full speed ahead. The $1.5 billion effort was launched a year ago, with UMass Medical School playing a major role in coordinating the push for fast, accessible COVID-19 testing.

    Read more
  • U.S. News & World Report ranks UMass Medical School 10th in the nation in primary care education
    Education News

    U.S. News & World Report ranks UMass Medical School 10th in the nation in primary care education

    UMass Medical School ranks 10th nationwide in primary care by U.S. News & World Report in its annual rankings of the best graduate schools. The 2022 report also marks a rise for UMMS in research, this year ranking 45th, up two spots from the previous ranking.

    Read more
  • New study of oral therapy candidate indicates positive results for patients with mild-to-moderate COVID-19
    Research News

    New study of oral therapy candidate indicates positive results for patients with mild-to-moderate COVID-19

    New research by Kaleido Biosciences, Inc., and UMass Medical School’s John P. Haran, MD, PhD, and Beth McCormick, PhD, shows that the company’s microbiome metabolic therapy candidate produced positive results in patients with mild-to-moderate COVID-19.

    Read more
  • Innovative neurosurgical technique used in Tay-Sachs gene therapy clinical trial
    Research News

    Innovative neurosurgical technique used in Tay-Sachs gene therapy clinical trial

    Oguz Cataltepe, MD, describes the innovative neurosurgical procedure used to treat patients in the new clinical trial for a gene therapy targeting infantile Tay-Sachs and Sandhoff diseases.

    Read more
  • Breast and prostate cancer screenings dropped during COVID-19 pandemic, UMMS study finds
    Research News

    Breast and prostate cancer screenings dropped during COVID-19 pandemic, UMMS study finds

    Breast and prostate cancer screenings declined rapidly in the early months of the COVID-19 pandemic compared with the same period a year earlier, according to a new study by UMass Medical School researchers working with Reliant Medical Group.

    Read more
  • First patient dosed in clinical trial of gene therapy for Tay-Sachs and Sandhoff diseases
    Research News

    First patient dosed in clinical trial of gene therapy for Tay-Sachs and Sandhoff diseases

    Sio Gene Therapies announced that the first patient with infantile Tay-Sachs disease has been dosed in a Phase I/II trial evaluating AXO-AAV-GM2, an investigational gene therapy for the treatment of GM2 gangliosidosis, which causes Tay-Sachs and Sandhoff diseases. Miguel Sena-Esteves, PhD, is a principal scientist of the research program at UMMS.

    Read more
  • UMMS researchers track COVID virus changes, community spread, as part of surveillance network
    Research News

    UMMS researchers track COVID virus changes, community spread, as part of surveillance network

    UMass Medical School researchers are working with a statewide network in partnership with the Broad Institute of MIT and Harvard and the U.S. Centers for Disease Control and Prevention to determine the extent of SARS-CoV-2 mutations in the Worcester area and what role they might play in community spread.

    Read more
  • UMass Medical School researchers to start trial of Moderna COVID-19 vaccine in teens
    Research News

    UMass Medical School researchers to start trial of Moderna COVID-19 vaccine in teens

    UMass Medical School researchers are about to start enrolling adolescents ages 12 through 17 in a clinical trial to test the COVID-19 mRNA vaccine made by Moderna.

    Read more
  • A healthy microbiome builds a strong immune system that could help defeat COVID-19
    Research News

    A healthy microbiome builds a strong immune system that could help defeat COVID-19

    In a piece written for The Conversation, Ana Maldonado-Contreras, PhD, explains why the army of microbes living inside your gut is essential for fighting off threats, including the virus that causes COVID-19.

    Read more
  • Researchers to study health care providers’ influence on COVID-19 vaccine acceptance
    Research News

    Researchers to study health care providers’ influence on COVID-19 vaccine acceptance

    Kimberly Fisher, MD, and Kathleen Mazor, EdD, are preparing a study to evaluate ways for health care providers to talk with their patients about the new COVID-19 vaccines and support them in getting vaccinated.

    Read more
  • Student-led virtual wellness program provides companionship to older, hospitalized COVID patients
    Education News

    Student-led virtual wellness program provides companionship to older, hospitalized COVID patients

    A new companionship wellness initiative at UMass Medical School is combating isolation and loneliness among COVID-19 patients 65 and older by having students virtually check in, comfort and emotionally support them at two Worcester hospitals.

    Read more
  • Robert Finberg details next steps for COVID vaccine
    Research News

    Robert Finberg details next steps for COVID vaccine

    Robert W. Finberg, MD, a member of Gov. Charlie Baker’s COVID-19 Vaccine Advisory Group, explains the process of getting the population vaccinated that will play out in phases over the coming year.

    Read more
  • New study co-authored by MD/PhD student Benjamin Helfand shows frequent delirium in older COVID patients
    Research News

    New study co-authored by MD/PhD student Benjamin Helfand shows frequent delirium in older COVID patients

    MD/PhD student Benjamin Helfand is co-first author on a study published in the Journal of American Medical Association Network Open that examines the frequency of COVID-19 positive older adults presenting to the emergency department with delirium.

    Read more
  • Women in Science: Ana Maldonado-Contreras pivots gut microbiome studies to tackle COVID-19
    Media, Research News

    Women in Science: Ana Maldonado-Contreras pivots gut microbiome studies to tackle COVID-19

    Ana Maldonado-Contreras, PhD, studies the gut microbiome and chronic disease, in particular inflammatory bowel disease, and is now working to understand how gut microbes can predispose patients to severe COVID complications.

    Read more
  • COVID-19 vaccine trial reports high effectiveness; UMass Medical School key enrollment site
    Research News

    COVID-19 vaccine trial reports high effectiveness; UMass Medical School key enrollment site

    First results from a Pfizer and BioNTech Phase III messenger RNA COVID-19 vaccine trial, in which UMass Medical School is participating, show promising findings, with more than 90 percent effectiveness in preventing infection with the SARS-CoV-2 virus, the companies announced.

    Read more
  • Sarah Nicole Forrester, Ann Moormann awarded $2 million NCI SeroNet grant
    Research News

    Sarah Nicole Forrester, Ann Moormann awarded $2 million NCI SeroNet grant

    Sarah Nicole Forrester, PhD, and Ann Moormann, PhD, MPH, are co-principal investigators on a new grant aimed at enhancing representation of Black and Hispanic people in SARS-CoV-2 immunology research through the use of storytelling.

    Read more
  • More than half of COVID-19 clinical trials exclude older adults, according to research co-authored by MD/PhD student Benjamin Helfand
    Research News

    More than half of COVID-19 clinical trials exclude older adults, according to research co-authored by MD/PhD student Benjamin Helfand

    A research letter published in JAMA Internal Medicine, co-authored by UMass Medical School MD/PhD student Benjamin Helfand, reports that older adults were likely to be excluded from more than 50 percent of COVID-19 clinical trials and 100 percent of vaccine trials initiated early in the pandemic.

    Read more
  • UMMS researchers study attitudes toward potential COVID-19 vaccine
    Research News

    UMMS researchers study attitudes toward potential COVID-19 vaccine

    As many as four in 10 adults would refuse or hesitate to get a COVID-19 vaccine, according to a national survey, results of which were published in the Annals of Internal Medicine. Study co-authors Kimberly Fisher, MD, and Kathleen Mazor, EdD, say the findings indicate that health education outreach would be necessary to achieve widespread uptake of a safe and effective vaccine.

    Read more
  • Boston Globe, CNN: UMass Medical School seeking to enroll diverse communities in COVID vaccine trial
    Media, Research News

    Boston Globe, CNN: UMass Medical School seeking to enroll diverse communities in COVID vaccine trial

    Robert Finberg, MD, spoke with the Boston Globe and CNN about measures UMass Medical School has taken to reach a diverse population as it recruits for its involvement in the Pfizer/ BioNTech vaccine trail for COVID-19.

    Read more
  • UMMS researcher co-directs project to enhance diversity in biomedical sciences workforce
    Research News

    UMMS researcher co-directs project to enhance diversity in biomedical sciences workforce.

    Mary Munson, PhD, is co-directing a first-of-its-kind national program to enhance diversity in the academic biomedical workforce, funded by a $1.3 million, five-year grant from the National Institutes of Health.

    Read more
  • UMass Medical School announces participation and enrollment for vaccine trial candidate against COVID-19
    Research News

    UMass Medical School announces participation and enrollment for vaccine trial candidate against COVID-19

    UMass Medical School is enrolling healthy volunteers to take part in a Phase II/III clinical trial testing whether a messenger RNA vaccine candidate can prevent infection with the virus that causes COVID-19.

    Read more
  • Genomic analysis reveals many species may be vulnerable to SARS-CoV-2
    Research News

    Genomic analysis reveals many species may be vulnerable to SARS-CoV-2

    A new study from scientists at UMass Medical School and the University of California, Davis, reveals that humans are not the only species facing a potential threat from SARS-CoV-2, the novel coronavirus that causes COVID-19.

    Read more
  • National Institute on Aging grant aims to create roadmap for COVID-19 trials in nursing homes
    Research News

    National Institute on Aging grant aims to create roadmap for COVID-19 trials in nursing homes

    Jerry Gurwitz, MD, is principal investigator of a grant to develop a roadmap for developing clinical trials networks to study COVID-19 in nursing homes, as residents comprise more than 40 percent of deaths attributed to the pandemic nationwide.

    Read more
  • UMass Medical School receives $100 million in NIH grants to lead push for fast, accessible COVID-19 tests
    Research News

    UMass Medical School receives $100 million in NIH grants to lead push for fast, accessible COVID-19 tests

    UMass Medical School has been awarded grants totaling more than $100 million to coordinate the nationwide push for fast, accessible COVID-19 testing, playing a major role in the National Institutes of Health’s Rapid Acceleration of Diagnostics, or RADx, program.

    Read more
  • UMass research and development expenditures rise to record $684 million
    Research News

    UMass research and development expenditures rise to record $684 million

    Research expenditures at the University of Massachusetts increased by $33 million in one fiscal year to a record high of $684 million in fiscal year 2019. At UMass Medical School, research expenditures rose by 2.7 percent to $281.51 million.

    Read more
  • Greater Worcester COVID-19 Community Health Survey underway
    Community News

    Greater Worcester COVID-19 Community Health Survey underway

    UMass Medical School is conducting a community-facing survey in Worcester and six surrounding communities to assess how COVID-19 has affected ongoing day-to-day needs and help localities target relief efforts.

    Read more
  • Katherine Fitzgerald and Anastasia Khvorova named Harrington Scholars
    Research News

    Katherine Fitzgerald and Anastasia Khvorova named Harrington Scholars

    The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, in collaboration with Morgan Stanley GIFT Cures, has chosen two UMass Medical School faculty members to receive Harrington Scholar Awards for Coronavirus.

    Read more
  • UMass Medical School and UMass Memorial create risk scoring tool to triage COVID-19 patients
    Research News

    UMass Medical School and UMass Memorial create risk scoring tool to triage COVID-19 patients

    David McManus, MD, and MD/PhD candidate Apurv Soni developed a tool to predict risk of severe illness in COVID-19 patients.

    Read more
  • UMass Medical School researchers ramp up COVID-19 convalescent plasma study
    Research News

    UMass Medical School researchers ramp up COVID-19 convalescent plasma study

    More than 100 critically ill COVID-19 patients in the UMass Memorial Health Care system have been treated with convalescent plasma through a UMass Medical School clinical trial led by Jonathan M. Gerber, MD.

    Read more
  • Virus-like particles developed for RSV may hold key to COVID-19 vaccine, UMMS researcher says
    Research News

    Virus-like particles developed for RSV may hold key to COVID-19 vaccine, UMMS researcher says

    Trudy Morrison, PhD, is the featured speaker at the Hudson Hoagland Society’s 35th annual meeting, to be held virtually on Wednesday, May 20.

    Read more
  • Mass Consortium on Pathogen Readiness awards COVID-19 research funding to three UMass Medical School projects
    Research News

    Mass Consortium on Pathogen Readiness awards COVID-19 research funding to three UMass Medical School projects

    Research into COVID-19 by UMass Medical School scientists Ann Moormann, PhD, MPH; Robert Finberg, MD; and Jeremy Luban, MD, is being funded by the Massachusetts Consortium on Pathogen Readiness.

    Read more
  • NIH invests in rapid innovation and development for COVID-19 testing
    Research News

    NIH invests in rapid innovation and development for COVID-19 testing

    The Center for Advancing Point of Care Technologies, co-directed by David McManus, MD, at UMass Medical School, will perform a key role in a new National Institutes of Health initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies.

    Read more
  • Telegram: Robert Finberg explains UMass Medical School role in promising COVID-19 drug trial
    Research News

    Telegram: Robert Finberg explains UMass Medical School role in promising COVID-19 drug trial

    Thirty-one patients with severe COVID-19 were enrolled in the randomized, controlled trial of the drug remdesivir at UMass Memorial Medical Center’s University and Memorial campuses, overseen by lead investigator Robert W. Finberg, MD.

    Read more
  • Fujifilm announces a Phase II clinical trial of influenza antiviral drug for COVID-19
    Research News

    Fujifilm announces a Phase II clinical trial of influenza antiviral drug for COVID-19

    Fujifilm Corporation announced the initiation of a Phase II clinical trial in the United States to evaluate the safety and efficacy of its antiviral drug Avigan for patients with COVID-19, in collaboration with Brigham and Women’s Hospital, Massachusetts General Hospital and UMass Medical School. Robert W. Finberg, MD, is the principal investigator for the UMMS site.

    Read more
  • UMass Medical School, GE Healthcare Life Sciences to establish viral vector manufacturing facility
    Research News

    UMass Medical School, GE Healthcare Life Sciences to establish viral vector manufacturing facility

    UMass Medical School and GE Healthcare Life Sciences will establish a new, large-scale viral vector manufacturing facility, able to provide large quantities of high-quality recombinant adeno-associated virus vectors for preclinical research on the UMMS campus in Worcester.

    Read more